IRIS UniCatt

Rocca, Bianca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.462
AS - Asia 5.390
EU - Europa 5.113
SA - Sud America 1.227
AF - Africa 174
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.408
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.243
SG - Singapore 2.479
DE - Germania 1.338
CN - Cina 1.193
BR - Brasile 987
SE - Svezia 795
IT - Italia 710
UA - Ucraina 522
VN - Vietnam 486
FR - Francia 481
IE - Irlanda 292
GB - Regno Unito 214
ID - Indonesia 196
FI - Finlandia 184
IN - India 175
HK - Hong Kong 159
RU - Federazione Russa 142
PL - Polonia 139
BD - Bangladesh 135
JP - Giappone 126
CA - Canada 108
AR - Argentina 101
TR - Turchia 93
IQ - Iraq 69
MX - Messico 65
ES - Italia 53
NL - Olanda 47
KR - Corea 38
ZA - Sudafrica 38
BE - Belgio 35
AT - Austria 33
AU - Australia 32
CO - Colombia 31
EC - Ecuador 31
PK - Pakistan 31
CZ - Repubblica Ceca 29
IR - Iran 27
SA - Arabia Saudita 27
CI - Costa d'Avorio 25
ET - Etiopia 24
CH - Svizzera 22
VE - Venezuela 21
PH - Filippine 20
PE - Perù 17
CL - Cile 16
MY - Malesia 12
DZ - Algeria 11
EG - Egitto 11
JO - Giordania 11
PY - Paraguay 11
TN - Tunisia 11
UZ - Uzbekistan 11
IL - Israele 10
MA - Marocco 10
KE - Kenya 9
LV - Lettonia 9
NP - Nepal 9
GH - Ghana 8
OM - Oman 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
GR - Grecia 7
KZ - Kazakistan 7
NG - Nigeria 7
NO - Norvegia 7
TW - Taiwan 7
UY - Uruguay 7
AZ - Azerbaigian 6
BG - Bulgaria 6
HN - Honduras 6
JM - Giamaica 6
KW - Kuwait 6
MK - Macedonia 6
SN - Senegal 6
AL - Albania 5
BH - Bahrain 5
BO - Bolivia 5
LT - Lituania 5
PT - Portogallo 5
RO - Romania 5
TT - Trinidad e Tobago 5
AO - Angola 4
BY - Bielorussia 4
DK - Danimarca 4
KG - Kirghizistan 4
MN - Mongolia 4
PR - Porto Rico 4
XK - ???statistics.table.value.countryCode.XK??? 4
HU - Ungheria 3
LB - Libano 3
MT - Malta 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
SV - El Salvador 3
TJ - Tagikistan 3
AM - Armenia 2
Totale 19.370
Salva come PNG Salva come JPEG
Città #
Singapore 1.210
Ashburn 979
San Jose 667
Chandler 659
Dublin 284
Jacksonville 259
Beijing 248
San Mateo 225
Los Angeles 182
Jakarta 170
Wilmington 170
New York 166
Nanjing 154
Lauterbourg 148
Ho Chi Minh City 147
Rome 146
Hong Kong 142
Hanoi 124
Warsaw 124
Woodbridge 120
Milan 110
Ann Arbor 106
Houston 106
Tokyo 105
Hefei 102
Boston 98
St Louis 98
Munich 97
Lawrence 92
Cattolica 88
Chicago 79
Dallas 75
Frankfurt am Main 72
Dearborn 71
Fairfield 70
Buffalo 66
Moscow 66
Santa Clara 64
Seattle 64
São Paulo 64
Nürnberg 59
Redwood City 59
Princeton 54
Izmir 48
Helsinki 47
Atlanta 39
Nanchang 38
Tianjin 37
Nuremberg 35
Council Bluffs 34
Boardman 33
Shenyang 33
The Dalles 33
Mountain View 32
Da Nang 30
Kent 30
Paris 29
Seoul 29
Brooklyn 28
Toronto 28
Brussels 27
Orem 27
Turku 26
University Park 26
Abidjan 25
Hangzhou 25
London 25
Redmond 25
Shanghai 25
Zhengzhou 25
Denver 24
Detroit 24
Hebei 24
Hyderabad 24
Amsterdam 23
Bremen 23
Montreal 23
Brasília 22
Brno 22
Guangzhou 22
Kunming 22
Phoenix 22
Rio de Janeiro 22
Belo Horizonte 21
Haiphong 21
Pune 21
Augusta 19
Baghdad 19
Cambridge 19
Dhaka 19
Johannesburg 19
Washington 19
San Francisco 18
Vienna 18
Bareggio 17
Chennai 17
Wayne 17
Federal 16
Hounslow 16
Marseille 16
Totale 9.637
Salva come PNG Salva come JPEG
Nome #
Prolonged fasting promotes systemic inflammation and platelet activation in humans: a medically supervised, water-only fasting and refeeding study 684
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 346
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 333
More, more, more: Reducing thrombosis in acute coronary syndromes beyond dual antiplatelet therapy-current data and future directions 284
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 265
Mean Platelet Volume, Platelet Distribution Width, and Platelet Count in Type 2 Diabetes Mellitus, Impaired Fasting Glucose, and Metabolic Syndrome: systematic review and meta-analysis 256
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 253
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 228
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. 202
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study 196
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 193
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 179
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 174
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 173
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 172
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 170
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 170
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 169
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13. A new prothrombotic mechanism associated with oxidative stress 164
Effect of fibrinogen concentration on the velocity of platelet aggregation. 164
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 163
Increased thromboxane biosynthesis in essential thrombocythemia. 159
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 158
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 156
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 149
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 147
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 146
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 144
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 142
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 140
Drug insight: aspirin resistance- fact or fashion 135
Determinants of the interindividual variability in response to antiplatelet drugs. 134
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 132
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis 132
Aspirin: promise and resistance in the new millennium. 131
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 131
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 131
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 128
LACK OF AN ASSOCIATION BETWEEN INHERITED THROMBOPHILIC RISK FACTORS AND IDIOPATIC SUDDEN SENSORINEURAL HEARING LOSS IN ITALIAN PATIENTS 126
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 125
Aspirin, stroke and drug-drug interactions 124
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 123
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 122
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 122
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythemia 122
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. 121
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia 121
Fechtner syndrome: report of a third family and literature review 120
Another family with IGPS 119
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 119
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 119
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 118
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 117
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 117
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 117
The future of antiplatelet therapy in cardiovascular disease 116
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. 116
Homocysteinemia is inversely correlated with platelet count and inversely correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase 115
Farmaci antipiastinici 115
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 115
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 115
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 115
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 115
Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features 114
Type 2 Diabetes, Obesity, and Aspirin Responsiveness* 114
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 113
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 112
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 112
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 112
Effect of ketorolac, ketoprofen and nefopam on platelet function 112
Role of prostacyclin in the cardiovascular response to thromboxane A2 112
Identifying determinants of variability to tailor aspirin therapy 112
Platelet progenitors: the hidden drug target 112
Eicosanoid biosynthesis and metabolism in myeloproliferative disorders 109
Cyclooxygenases and prostaglandins: shaping up the immune response 109
Aspirin, 110 years later 108
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 106
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 106
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 105
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment 105
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease 105
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects 104
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 102
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 102
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 101
Aspirin and Other COX-1 Inhibitors 101
Nonsteroidal antiinflammatory drugs: past, present and future 101
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation 98
Increased thromboxane metabolites excretion in liver cirrhosis. 98
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin 98
Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation 98
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 98
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis 97
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 97
Familial autoimmune myasthenia gravis with different pathogenetic antibodies 97
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 97
Antithrombotic therapy in diabetes: which, when, and for how long? 97
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 96
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. 95
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 95
Totale 14.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.145 157 93 13 73 86 32 32 187 44 33 175 220
2022/20232.133 313 301 176 241 175 237 75 172 257 43 95 48
2023/20241.357 43 348 42 179 80 132 97 29 28 69 136 174
2024/20252.510 61 54 196 89 199 67 36 155 416 214 556 467
2025/20267.688 1.124 208 530 733 1.056 330 1.221 352 479 582 341 732
2026/2027407 407 0 0 0 0 0 0 0 0 0 0 0
Totale 19.632